NAT10 and neoplasm: Compared with the control group, the NAT10 knockdown group showed a significant inhibition in the growth of tumours, and the group treated with the NAT10 inhibitor Remodelin also showed a significant inhibition in the growth of tumours (Fig. 4c–e).